Simon Geißler
Impact in
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 3
- Lipid Membrane Structure and Behavior 2
-
- Drug Solubulity and Delivery Systems 4
- Advanced Drug Delivery Systems 3
- Co-authors
- Achim Goepferich (4 shared papers)Markus Weigandt (5 shared papers)Sandra Breyer (3 shared papers)Walter Mier (3 shared papers)Uwe Haberkorn (3 shared papers)Tobias Miller (2 shared papers)Gert Fricker (1 shared paper)Meike Harms (1 shared paper)
- Journals
- International Journal of Pharmaceutics (6 papers)Journal of Controlled Release (2 papers)Pharmaceutical Research (1 paper)Molecular Pharmaceutics (1 paper)International Journal of Pharmaceutics X (1 paper)
- Partner nations
- GermanySwitzerlandUganda
In The Last Decade
Simon Geißler
12 papers receiving 321 citations
Peers
Comparison fields: 5 of 87
- Pharmaceutical Science 86
- Biomaterials 120
- Automotive Engineering 43
- Molecular Medicine 13
- Biomedical Engineering 106
Countries citing papers authored by Simon Geißler
This map shows the geographic impact of Simon Geißler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Geißler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Geißler more than expected).
Fields of papers citing papers by Simon Geißler
This network shows the impact of papers produced by Simon Geißler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Geißler. The network helps show where Simon Geißler may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon Geißler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 69 | |
| 2 | 2021 | 62 | |
| 3 | 2017 | 53 | |
| 4 | 2012 | 38 | |
| 5 | 2015 | 24 | |
| 6 | 2011 | 24 | |
| 7 | 2016 | 22 | |
| 8 | 2013 | 11 | |
| 9 | 2013 | 9 | |
| 10 | 2012 | 8 | |
| 11 | 2024 | 3 | |
| 12 | 2015 | 2 | |
| 13 | 2016 | 1 | |
| 14 | 2025 | 0 |
About Simon Geißler
Simon Geißler is a scholar working on Molecular Biology, Pharmaceutical Science, Biomedical Engineering, Biomaterials and Automotive Engineering, having authored 14 papers that have together received 326 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (4 papers), RNA Interference and Gene Delivery (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Advanced Drug Delivery Systems (3 papers), Lipid Membrane Structure and Behavior (2 papers), Additive Manufacturing and 3D Printing Technologies (2 papers), Pharmaceutical studies and practices (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Pharmaceutical Science (86 citations), Biomaterials (120 citations), Automotive Engineering (43 citations), Molecular Medicine (13 citations) and Biomedical Engineering (106 citations). Simon Geißler has collaborated with scholars based in Germany, Switzerland and Uganda. Frequent co-authors include Achim Goepferich, Markus Weigandt, Sandra Breyer, Walter Mier, Uwe Haberkorn, Tobias Miller, Gert Fricker, Meike Harms, Karsten Mäder and Thomas Kipping. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Controlled Release, Pharmaceutical Research, Molecular Pharmaceutics and International Journal of Pharmaceutics X.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.